Abstract:Background: T cells play a pivotal role in chemotherapy-triggered anti-tumor effects. Emerging evidence underscores the link between impaired anti-tumor immune responses and resistance to paclitaxel therapy in triple-negative breast cancer (TNBC). Tumor-related endothelial cells (ECs) have potential immunoregulatory activity. However, how ECs regulate T cell activity during TNBC chemotherapy remains poorly understood. Methods: Single-cell analysis of ECs in patients with TNBC receiving paclitaxel therapy was performed using an accessible single-cell RNA sequencing (scRNA-seq) dataset to identify key EC subtypes and their immune characteristics. An integrated analysis of a tumor-bearing mouse model, immunofluorescence, and a spatial transcriptome dataset revealed the spatial relationship between ECs, especially Tumor necrosis factor receptor (TNFR) 2+ ECs, and CD8+ T cells. RNA sequencing, CD8+ T cell proliferation assays, flow cytometry, and bioinformatic analyses were performed to explore the immunosuppressive function of TNFR2 in ECs. The downstream metabolic mechanism of TNFR2 was further investigated using RNA sequencing, cellular glycolysis assays, and western blotting. Results: In this study, we identified an immunoregulatory EC subtype, characterized by enhanced TNFR2 expression in non-responders. By a mouse model of TNBC, we revealed a dynamic reduction in the proportion of the CD8+ T cell-contacting tumor vessels that could co-localize spatially with CD8+ T cells during chemotherapy and an increased expression of TNFR2 by ECs. TNFR2 suppresses glycolytic activity in ECs by activating NF-κB signaling in vitro. Tuning endothelial glycolysis enhances programmed death-ligand (PD-L) 1-dependent inhibitory capacity, thereby inducing CD8+ T cell suppression. In addition, TNFR2+ ECs showed a greater spatial affinity for exhausted CD8+ T cells than for non-exhausted CD8+ T cells. TNFR2 blockade restores impaired anti-tumor immunity in vivo, leading to the loss of PD-L1 expression by ECs and enhancement of CD8+ T cell infiltration into the tumors. Conclusions: These findings reveal the suppression of CD8+ T cells by ECs in chemoresistance and indicate the critical role of TNFR2 in driving the immunosuppressive capacity of ECs via tuning glycolysis. Targeting endothelial TNFR2 may serve as a potent strategy for treating TNBC with paclitaxel.

Autocrine TNF-α-mediated NF-κB Activation is a Determinant for Evasion of CD40-induced Cytotoxicity in Cancer Cells

Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells.

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy

CD40 ligation-induced ERK activation promotes autophagy which leads to enhanced radiosensitivity in cervical carcinoma cells

Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation

Inhibition of Iung cancer cell proliferation by CD40 signaling through tumor necrosis factor I

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Tumor Necrosis Factor and Cancer, Buddies or Foes?

TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells

Transmembrane Tnf-Alpha Mediates "forward" and "reverse" Signaling, Inducing Cell Death or Survival Via the Nf-Kappa B Pathway in Raji Burkitt Lymphoma Cells

Autophagy Attenuates Tnf-Alpha-Induced Proliferation Inhibition In The A375 Melanoma Cell Line

Role of Nf Kappa B Activator Act1 in Cd40-Mediated Signaling in Epithelial Cells

Transmembrane TNF-A Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2

Harnessing the potential of CD40 agonism in cancer therapy

Transmembrane Tumor Necrosis Factor-Α Promotes the Recruitment of MDSCs to Tumor Tissue by Upregulating CXCR4 Expression Via TNFR2

Soluble CXCL16 Promotes TNF‐α‐induced Apoptosis in DLBCL Via the AMAD10‐NF‐κB Regulatory Feedback Loop

Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF

Autophagy protects tumors from T cell-mediated cytotoxicity via inhibition of TNF-induced apoptosis

NR4A1-induced Increase in the Sensitivity of a Human Gastric Cancer Line to TNFα-mediated Apoptosis is Associated with the Inhibition of JNK/Parkin-dependent Mitophagy.